Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement

By Horwitz EM   Le Blanc K   Dominici M   Mueller I   Slaper-Cortenbach I   Marini FC   Deans RJ   Krause DS   Keating A  

Cytotherapy, Vol. 7, Iss. 5, 2005-11 ,pp. : 393-395

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Defining the risks of mesenchymal stromal cell therapy

By Prockop Darwin J.   Brenner Malcolm   Fibbe Willem E.   Horwitz Edwin   Le Blanc Katarina   Phinney Donald G.   Simmons Paul J.   Sensebe Luc   Keating Armand  

Cytotherapy, Vol. 12, Iss. 5, 2010-09 ,pp. : 576-578

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Lifespan of human amniotic fluid-derived multipotent mesenchymal stromal cells

By Miranda-Sayago Jose Maria   Fernáández-Arcas Nieves   Benito Carmen   Reyes-Engel Armando   Carrera Jorge   Alonso Antonio  

Cytotherapy, Vol. 13, Iss. 5, 2011-05 ,pp. : 572-581

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways

By Göötherströöm Cecilia   Lundqvist Andreas   Duprez Ida Rasmusson   Childs Richard   Berg Louise   le Blanc Katarina  

Cytotherapy, Vol. 13, Iss. 3, 2011-03 ,pp. : 269-278

Ashgate Publishing Ltd

Access to resources Recommend Favorite

No increased trapping of multipotent mesenchymal stromal cells in bone marrow filters compared with other bone marrow cells

By Sundin M.   Remberger M.   Lonnies H.   Sundberg B.   Ringden O.   Blanc K Le  

Cytotherapy, Vol. 10, Iss. 3, 2008-03 ,pp. : 238-242

Ashgate Publishing Ltd

Access to resources Recommend Favorite